Progress in Nanomedicine: Approved and Investigational Nanodrugs

摘要

Nanomedicine is a relatively new and rapidly evolving field combining nanotechnology with the biomedical and pharmaceutical sciences.Nanoparticles (NPs) can impart many pharmacokinetic, efficacy, safety, and targeting benefits when they are included in drug formulations. Many nanodrugs have entered clinical practice, and even more are being investigated in clinical trials for a wide variety of indications. However, nanopharmaceuticals also face challenges, such as the need for better characterization, possible toxicity issues, a lack of specific regulatory guidelines, cost-benefit considerations, and waning enthusiasm among some health care professionals.For these reasons, expectations regarding nanodrugs that are in early stages of development or clinical trials need to remain realistic.